Novo Nordisk | NVO - Debitur Perdagangan





Debitur Perdagangan Perubahan Tanggal
ANI Pharmaceuticals USD 255.43M 25.65M 2026-03
Aurora Cannabis CAD 48.26M 1.53M 2025-12
Bausch Health Companies USD 2.19B 160M 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Canopy Growth CAD 140.42M 113.56M 2025-12
Corcept Therapeutics USD 39.07M 20.71M 2026-03
Drreddys Laboratories INR 1.41B 11.6M 2025-12
Eli Lilly USD 21.18B 1.02B 2026-03
GlaxoSmithKline GBP 7.94B 178M 2026-03
Merck USD 11.78B 345M 2025-12
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Novartis USD 9.6B 2.69B 2026-03
Novo Nordisk DKK 106.26B 11.21B 2026-03
Novo Nordisk DKK 14.27B 72.1B 2025-06
Pacira USD 125.64M 1.57M 2026-03
Perrigo USD 697.1M 84.3M 2026-03
Phibro Animal Health USD 215.87M 2.02M 2025-12
Prestige Brands USD 190.46M 8.54M 2025-12
Sanofi EUR 482M 85M 2026-03
Supernus Pharmaceuticals USD 182.18M 5.62M 2026-03
Zoetis USD 1.51B 84M 2026-03